beta-glycerophosphoric acid has been researched along with Osteoporosis in 2 studies
beta-glycerophosphoric acid: plays role in mineralization of bone in vitro
glycerol 2-phosphate : A glycerol monophosphate having the phosphate group at the 2-position.
Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Alendronate (ALN) is a BCS III bone resorption inhibitor, with very poor oral bioavailability." | 5.48 | Alendronate-loaded, biodegradable smart hydrogel: a promising injectable depot formulation for osteoporosis. ( Boraie, N; Nafee, N; Zewail, M, 2018) |
| "The objectives of this work were to: (1) establish methodology for pretreating osteoblast-like cells in vitro with dexamethasone to cause glucocorticoid-induced osteoporosis, (2) perform quantitative and qualitative assessments of cellular attachment of osteoporosis-like osteoblasts when grown on implant surfaces of differing roughness, (3) and explore the hypothesis that dexamethasone-treated osteoblasts have altered cell attachment properties by focal adhesion disassembly and decreased tyrosine phosphorylation of the focal adhesion tyrosine kinase." | 3.73 | Effect of glucocorticoid-induced osteoporotic-like conditions on osteoblast cell attachment to implant surface microtopographies. ( Cho, P; Keller, JC; Kellogg, B; Schneider, GB; Zaharias, R, 2006) |
| "Alendronate (ALN) is a BCS III bone resorption inhibitor, with very poor oral bioavailability." | 1.48 | Alendronate-loaded, biodegradable smart hydrogel: a promising injectable depot formulation for osteoporosis. ( Boraie, N; Nafee, N; Zewail, M, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nafee, N | 1 |
| Zewail, M | 1 |
| Boraie, N | 1 |
| Cho, P | 1 |
| Schneider, GB | 1 |
| Kellogg, B | 1 |
| Zaharias, R | 1 |
| Keller, JC | 1 |
2 other studies available for beta-glycerophosphoric acid and Osteoporosis
| Article | Year |
|---|---|
Alendronate-loaded, biodegradable smart hydrogel: a promising injectable depot formulation for osteoporosis.
Topics: Alendronate; Animals; Bone Density Conservation Agents; Calorimetry, Differential Scanning; Chemistr | 2018 |
Effect of glucocorticoid-induced osteoporotic-like conditions on osteoblast cell attachment to implant surface microtopographies.
Topics: 3T3 Cells; Animals; Antioxidants; Ascorbic Acid; Blotting, Western; Cell Adhesion; Cell Line; Cell P | 2006 |